NanoBase™ Epilingual is a lecithin-based tri-domain delivery Architecture engineered for consumable delivery. It ships active-free. Your team loads the actives. One modern platform for pharmaceutical and dietary-supplement development.
The problem
Topical formulation is migrating off 1949 HLB emulsion physics onto nanoscale architecture. Consumable delivery has the same legacy problem and has moved slower. Conventional powders, standard capsules, and macro-scale emulsified actives share one failure: the active is coarse, poorly dispersed, and much of the dose never reaches uptake.
Formulators overdose to compensate. That raises cost, strains tolerability, and does nothing for batch-to-batch consistency. The same architectural shift replacing HLB in topical formulation replaces macro-scale delivery in consumables.
The Architecture
NanoBase™ Epilingual is not a single-architecture liposome or nanoemulsion. Three delivery domains coexist in one lecithin-based chassis, held by a DLVO electrostatic design principle that keeps the population physically stable and resists domain coalescence.
Carries lipophilic and poorly water-soluble actives.
Phospholipid vesicles for structured encapsulation.
Solubilizes polar and water-loving actives.
Three architectures in one carrier means lipophilic, structured, and polar actives can travel in the same system. That is the structural feature that separates NanoBase™ Epilingual from single-architecture consumable delivery systems.
The NanoBase™ Architecture is developed at Pensive Beauty Nanoscience Labs, where the underlying delivery science is documented.
Supplied empty. Plug and play.
NanoBase™ Epilingual is a finished, self-complete delivery Architecture. You do not rebuild matrix functions it already contains. You dose your actives into it.
The platform is broad and designed for plug-and-play use across a wide range of actives and consumable formats.
The same Architecture serves pharmaceutical and dietary-supplement development. Your finished product, your positioning.
What you make, how you validate it, and how you classify it are yours to control.
Who it serves
A modern nanoscale carrier platform to evaluate for oral and sublingual programs, supplied active-free so your team formulates and validates your own actives under your own protocols.
A tri-domain alternative to single-architecture liposomal systems for functional ingredients, adaptable across sublingual and oral consumable formats.
Questions
A lecithin-based tri-domain nanoscale delivery platform for oral and sublingual consumable formats. It is supplied active-free. Formulators load their own actives, so the same platform serves both pharmaceutical and dietary-supplement development.
Standard liposomal and nanoemulsion systems are single-architecture. NanoBase™ Epilingual is tri-domain: nanoemulsion, vesicular, and micellar domains coexist in one lecithin-based chassis, held by a DLVO electrostatic design principle that resists domain coalescence. One platform can carry lipophilic, structured, and polar actives together.
Neither. It is a delivery platform supplied active-free. The regulatory classification of any finished product and its clinical or regulatory validation are the responsibility of the developing party.
Oral and sublingual consumable formats, designed for plug-and-play use across a broad range of actives.
Yes. Request the platform brief and we will start in writing so every detail is exact and on record.
Get started
Tell us the format and the actives you are developing. We work in writing so every claim stays exact and substantiated.
Email team@pensivebeauty.com